C&CAUSES & WHAT WE KNOW
Causes & What We Know/October 24, 2026/2 min read

New Genetic Study Finds No Clear Link Between Type 1 Diabetes and Brain Tumors

Researchers used genetic analysis to examine whether diabetes increases meningioma risk. The study found no significant connection for Type 1 diabetes, offering reassurance to the T1D community.

Research summaryPubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

causesautoimmunitygeneticsrisk

Key takeaways

  • A large genetic study of over 590,000 people with Type 1 diabetes found no meaningful association between T1D and meningioma (a type of brain tumor)
  • Type 2 diabetes showed only a weak, unreliable association with lower meningioma risk that did not hold up after statistical correction
  • Blood sugar levels (measured by HbA1c, fasting glucose, and post-meal glucose) were not linked to meningioma risk
  • This research used Mendelian randomization, a genetic method that helps identify true causal relationships rather than coincidental associations
  • While reassuring, more research is needed to understand why earlier studies reported mixed results

What This Study Looked At

For years, doctors and researchers have noticed that some studies report a connection between diabetes and meningioma—a tumor that grows in the membrane surrounding the brain and spinal cord—while others do not. This confusion prompted researchers to dig deeper using genetic data.

Scientists analyzed genetic information from nearly 591,000 people with Type 1 diabetes, 468,000 with Type 2 diabetes, and thousands more with various blood sugar measurements. They compared this data against meningioma cases from over 377,000 people. The goal was to determine whether diabetes actually *causes* higher meningioma risk, or whether the earlier associations were coincidental.

Key Findings for Type 1 Diabetes

The study found no significant genetic link between Type 1 diabetes and meningioma. This is important news: it suggests that having T1D does not increase your genetic risk for developing this type of brain tumor.

Researchers also looked at specific blood sugar markers—hemoglobin A1c (which shows average blood sugar over months), fasting glucose, and glucose after eating—and found none of these were associated with meningioma risk either.

What About Type 2 Diabetes?

Type 2 diabetes showed a weak statistical association with *lower* meningioma risk in the initial analysis. However, this finding did not remain reliable after researchers applied strict statistical corrections to account for multiple comparisons. This means the finding was likely due to chance rather than a true biological relationship.

Why This Matters and What Remains Unknown

This study uses a powerful genetic method called Mendelian randomization, which is better at finding true cause-and-effect relationships than traditional epidemiological studies. The absence of a clear genetic link for Type 1 diabetes is reassuring and helps explain why earlier research gave mixed results.

However, this is one study. Scientists note that earlier conflicting findings remain unexplained, and more research may help clarify why different studies came to different conclusions. If you have concerns about your personal health risks, speak with your healthcare provider, who can assess your individual situation.

Evidence label

Source: IBRO neuroscience reports. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

From Type1Cure

Read more of our own writing in Stories

More evidence-labeled coverage across the Type1Cure library.